These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20678572)

  • 21. [Morphology of basement membrane and associated matrix proteins in normal and pathological tissues].
    Nerlich A
    Veroff Pathol; 1995; 145():1-139. PubMed ID: 8638427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual activities of 22-24 kDA basic fibroblast growth factor: inhibition of migration and stimulation of proliferation.
    Piotrowicz RS; Maher PA; Levin EG
    J Cell Physiol; 1999 Feb; 178(2):144-53. PubMed ID: 10048578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding constant measurements for inhibitors of growth factor binding to heparan sulfate proteoglycans.
    Forsten KE; Nugent MA
    Methods Mol Biol; 2001; 171():415-26. PubMed ID: 11450256
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.
    Ritter E; Perry A; Yu J; Wang T; Tang L; Bieberich E
    Ann Surg; 2008 Feb; 247(2):310-4. PubMed ID: 18216538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Human heparanase: roles in invasion and metastasis of cancer].
    Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
    Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal membrane heparan sulphate proteoglycan expression during wound healing in human skin.
    Andriessen MP; van den Born J; Latijnhouwers MA; Bergers M; van de Kerkhof PC; Schalkwijk J
    J Pathol; 1997 Nov; 183(3):264-71. PubMed ID: 9422980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of alpha6 integrin in endothelial cells unveils a proangiogenic role for basement membrane.
    Primo L; Seano G; Roca C; Maione F; Gagliardi PA; Sessa R; Martinelli M; Giraudo E; di Blasio L; Bussolino F
    Cancer Res; 2010 Jul; 70(14):5759-69. PubMed ID: 20570893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations in mass transfer to single endothelial cells.
    Van Doormaal MA; Zhang J; Wada S; Shaw JE; Won D; Cybulsky MI; Yip CM; Ethier CR
    Biomech Model Mechanobiol; 2009 Jun; 8(3):183-93. PubMed ID: 18568449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of H2O2-induced oxidative stress in endothelial cells exposed to physiologic shear stress.
    Coyle CH; Kader KN
    ASAIO J; 2007; 53(1):17-22. PubMed ID: 17237644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP-binding on fibroblast growth factor 2 partially overlaps with the heparin-binding domain.
    Rose K; Pallast S; Klumpp S; Krieglstein J
    J Biochem; 2008 Sep; 144(3):343-7. PubMed ID: 18511454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells.
    Muthukrishnan L; Warder E; McNeil PL
    J Cell Physiol; 1991 Jul; 148(1):1-16. PubMed ID: 1860889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial cell capture of heparin-binding growth factors under flow.
    Zhao B; Zhang C; Forsten-Williams K; Zhang J; Fannon M
    PLoS Comput Biol; 2010 Oct; 6(10):e1000971. PubMed ID: 21060855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability.
    Morss AS; Edelman ER
    J Biol Chem; 2007 May; 282(19):14635-44. PubMed ID: 17327226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Heparin-Mimicking Block Copolymer Both Stabilizes and Increases the Activity of Fibroblast Growth Factor 2 (FGF2).
    Paluck SJ; Nguyen TH; Lee JP; Maynard HD
    Biomacromolecules; 2016 Oct; 17(10):3386-3395. PubMed ID: 27580376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of ATP with fibroblast growth factor 2: biochemical characterization and consequence for growth factor stability.
    Rose K
    BMC Biochem; 2011 Mar; 12():14. PubMed ID: 21447157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single event visualization of unconventional secretion of FGF2.
    Dimou E; Cosentino K; Platonova E; Ros U; Sadeghi M; Kashyap P; Katsinelos T; Wegehingel S; Noé F; García-Sáez AJ; Ewers H; Nickel W
    J Cell Biol; 2019 Feb; 218(2):683-699. PubMed ID: 30470711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular mechanism underlying unconventional secretion of Fibroblast Growth Factor 2 from tumour cells.
    Steringer JP; Nickel W
    Biol Cell; 2017 Nov; 109(11):375-380. PubMed ID: 28799166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors.
    Foglieni C; Pagano K; Lessi M; Bugatti A; Moroni E; Pinessi D; Resovi A; Ribatti D; Bertini S; Ragona L; Bellina F; Rusnati M; Colombo G; Taraboletti G
    Sci Rep; 2016 Mar; 6():23432. PubMed ID: 27000667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular growth factor binding kinetics to the endothelial cell basement membrane, with a kinetics-based correction for substrate binding.
    Clyne AM; Edelman ER
    Cytotechnology; 2009 Jul; 60(1-3):33. PubMed ID: 19639390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.